Different vascular response to concurrent implantation of sirolimus- and zotarolimus-eluting stents in the same vessel

Heart and Vessels

Volumn 24, Issue 4, 2009, Pages 313-316

  Cirillo, Plinio ^a   Rosa, Salvatore ^a   Palma, Vito ^a   Rosa, Roberta ^a   Maietta, Paola ^a   Piscione, Federico ^a   Chiariello, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Drug eluting stent; Restenosis; Sirolimus eluting stent; Zotarolimuseluting stent

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; RAPAMYCIN; ZOTAROLIMUS;

ADULT; AGED; ANAMNESIS; ANGIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; BLOOD VESSEL REACTIVITY; CASE REPORT; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; SYMPTOMATOLOGY; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSTHESIS DESIGN; SIROLIMUS; TREATMENT OUTCOME;

EID: 68249133788     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1134-x     Document Type: Article

References (13)

1. Serruys PW, De Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331:489-495
2. Kasaoka S, Tobis JM, Akiyama T, Reimers B, Di Mario C, Wong ND, Colombo A (1998) Angiographic and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol 32:1630-1635
3. Tanaka S, Watanabe S, Matsuo H, Segawa T, Iwama M, Hirose T, Takahashi H, Ono K, Warita S, Kojima T, Minatoguchi S, Fujiwara H (2008) Prospective randomized trial comparing a nitinol self-expanding coronary stent with low-pressure dilatation and a high-pressure balloon expandable bare metal stent. Heart Vessels 23:1-8
4. Kaul S, Shah PK, Diamond GA (2007) As time goes by: Current status and future directions in the controversy over stenting. J Am Coll Cardiol 50:128-137
5. Serruys PW, Kutryk MJB, Ong ATL (2006) Coronary-artery stents. N Engl J Med 354:483-495
6. Schampaert E, Moses JW, Schofer J, Schluter M, Gershlick AH, Cohen EA, Palisaitis DA, Breithardt G, Donohoe DJ, Wang H, Popma JJ, Kuntz RE, Leon MB (2006) Sirolimus-eluting stents at two years: A pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses. Am J Cardiol 98:36-41
7. Kandzari DE, Leon MB, Popma JJ, Fitzgerald PJ, O'shaughnessy C, Ball MW, Turco M, Applegate RJ, Gurbel PA, Midei MG, Badre SS, Mauri L, Thompson KP, LeNarz LA, Kuntz RE (2006) Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: A randomized controlled trial. J Am Coll Cardiol 48:2440-2447
8. Kandzari DE, Leon MB (2006) Overview of pharmacology and clinical trials program with the zotarolimus-eluting Endeavor stent. J Intervent Cardiol 19:405-413
9. Chen Y, Smith M, Sheets M, Ballaron S, Trevillyan J, Burke S, Rosenberg T, Henry C, Wagner R, Bauch R, Marsh K, Fey T, Hsieh G, Gauvin D, Mollison K, Carter G, Djuric S (2007) Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppression. J Cardiovasc Pharmacol 49: 228-235
10. Burzotta F, Siviglia M, Altamura L, Trani C, Leone AM, Romagnoli E, Mazzari MA, Mongiardo R, Niccoli G, Brancati M, Biondi-Zoccai G, Rebuzzi AG, Schiavoni G, Crea F (2007) Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stent. Am J Cardiol 99:364-368
11. Corbett SJ, Cosgrave J, Colombo A (2007) Concurrent implantation of sirolimus- and paclitaxel- eluting stents in the same vessel. Catheter Cardiovasc Interv 69:109-114
12. Sakurai R, Bonneau HN, Honda Y, Fitzgerald PJ (2007) Intravascular ultrasound findings in ENDEAVOR II and ENDEAVOR III. Am J Cardiol 100:S71-S76
13. Ozer N, Tangurek B, Firat F, Ozer S, Tartan Z, Ozturk R, Ozay B, Ciloglu F, Yilmaz H, Cam N (2008) Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Heart Vessels 23:75-82